Autologous serum eye drops with added hyaluronic acid in the conjunctival sac: a study of the residual time 2

Autologous serum eye drops with added hyaluronic acid in the conjunctival sac: a study of the residual time 2 - A study of autologous serum eye drops with added hyaluronic acid 2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007893

Enrollment

Registered

2012-05-14

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

keratoconjunctival dysfunction,severe dry eye,late-onset bleb leak after trabeculectomy

Interventions

apply 10 microliter autologous serum eye drops added hyaluronic acid(autologous serum 50%,hyaleinmini0.3,33%,cravit1.5, 16.7%),1 week,apply 10 microliter autologous serum eye drops added saline(autolo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: persons without severe keratoconjunctival dysfunction

Exclusion criteria

Exclusion criteria: paient with severe keratoconjunctival dysfunction

Design outcomes

Primary

Measure	Time frame
Albumin concentration in the conjunctival sac 5min., 10min., 15min., 20min. after administration of autologous serum eye drops added hyaluronic acid	—

Countries

Japan

Contacts

Public ContactHideto Sagara

Marui Eye Clinic Director

hide1234@ruby.ocn.ne.jp0244-24-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026